Abstract

The vertebrate main-body axis is laid down during embryonic stages in an anterior-to-posterior (head-to-tail) direction, driven and supplied by posteriorly located progenitors. Whilst posterior expansion and segmentation appears broadly uniform along the axis, there is developmental and evolutionary support for at least two discrete modules controlling processes within different axial regions: a trunk and a tail module. Here, we identify Nuclear receptor subfamily 6 group A member 1 (Nr6a1) as a master regulator of trunk development in the mouse. Specifically, Nr6a1 was found to control vertebral number and segmentation of the trunk region, autonomously from other axial regions. Moreover, Nr6a1 was essential for the timely progression of Hox signatures, and neural versus mesodermal cell fate choice, within axial progenitors. Collectively, Nr6a1 has an axially-restricted role in all major cellular and tissue-level events required for vertebral column formation, supporting the view that changes in Nr6a1 levels may underlie evolutionary changes in axial formulae.

The authors identify Nuclear receptor subfamily 6 group A member 1 (Nr6a1) as a master regulator of elongation, segmentation, patterning and lineage allocation specifically within the trunk region of the mouse, acting downstream of the major signals known to control vertebral column formation.

Details

Title
Nr6a1 controls Hox expression dynamics and is a master regulator of vertebrate trunk development
Author
Chang, Yi-Cheng 1 ; Manent, Jan 1 ; Schroeder, Jan 2   VIAFID ORCID Logo  ; Wong, Siew Fen Lisa 1 ; Hauswirth, Gabriel M. 1   VIAFID ORCID Logo  ; Shylo, Natalia A. 3 ; Moore, Emma L. 3   VIAFID ORCID Logo  ; Achilleos, Annita 4   VIAFID ORCID Logo  ; Garside, Victoria 1 ; Polo, Jose M. 2   VIAFID ORCID Logo  ; Trainor, Paul 5   VIAFID ORCID Logo  ; McGlinn, Edwina 1   VIAFID ORCID Logo 

 Monash University, EMBL Australia, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Monash University, Australian Regenerative Medicine Institute, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857) 
 Monash University, Australian Regenerative Medicine Institute, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Monash University, Department of Anatomy and Developmental Biology, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Monash Biomedicine Discovery Institute, Development and Stem Cells Program, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857) 
 Stowers Institute for Medical Research, Kansas City, USA (GRID:grid.250820.d) (ISNI:0000 0000 9420 1591) 
 Stowers Institute for Medical Research, Kansas City, USA (GRID:grid.250820.d) (ISNI:0000 0000 9420 1591); University of Nicosia, Nicosia, Cyprus (GRID:grid.413056.5) (ISNI:0000 0004 0383 4764) 
 Stowers Institute for Medical Research, Kansas City, USA (GRID:grid.250820.d) (ISNI:0000 0000 9420 1591); University of Kansas Medical Center, Department of Anatomy and Cell Biology, Kansas City, USA (GRID:grid.412016.0) (ISNI:0000 0001 2177 6375) 
Pages
7766
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2754660096
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.